Sarah Cannon Research Institute (SCRI) is one of the world’s leading oncology research organizations conducting community-based clinical trials. Focused on advancing therapies for patients, it is a leader in drug development and has contributed to pivotal research leading to the majority of new cancer therapies approved by the FDA today.
